PSPH Antikörper (AA 1-225)
Kurzübersicht für PSPH Antikörper (AA 1-225) (ABIN165446)
Target
Alle PSPH Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 1-225
-
Verwendungszweck
- Human Phosphoserine phosphatase/PSPH antibody
-
Aufreinigung
- Purified
-
Immunogen
- Recombinant human PSP (1-225aa) purified from E. coli
-
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
- Recommended dilution 1:1000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Phosphate-Buffered Saline ( pH 7.4) with 0.02 % Sodium Azide, 10 % glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing cycles
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.
-
-
- PSPH (Phosphoserine Phosphatase (PSPH))
-
Andere Bezeichnung
- Phosphoserine phosphatase/PSPH
-
Hintergrund
- Human phosphoserine phosphatase (HPSP), specific for D- and L- phosphoserine, has been identified in all human tissues. HPSP is a Mg (2+) -dependent phosphoserine phosphatase. The three dimensional structure of HPSP reveals the structural and functional role of the divalent cation in the active site of phosphatases. In particular, the complex structures reveal that the open-closed environmental change of the active site, generated by local rearrangement of the alpha-helical bundle domain, is important for the substrate recognition and hydrolysis.
-
NCBI Accession
- NP_004568
-
Pathways
- Warburg Effekt
Target
-